Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Cambridge Cognition inks strategic partnership with ActiGraph

(Sharecast News) - Brain health specialist Cambridge Cognition announced a strategic partnership with ActiGraph, a provider of wearable technologies tailored for clinical trials, on Wednesday. The AIM-traded firm said the collaboration was intended to yield a comprehensive suite of assessments, offering a holistic perspective on both mental and physical capabilities.

At the core of the partnership was ActiGraph's 'Accelerant' partnership programme, which was intended to propel the use of digital health technologies (DHTs) within clinical development by streamlining access to raw data streams for clinical research organisations (CROs) and technology vendors.

In the context of the new alliance, Cambridge Cognition said it and ActiGraph would use their expertise in digital data collection to augment assessment capabilities within central nervous system (CNS) trials, particularly in domains marked by significant unmet needs such as schizophrenia and dementia.

Cambridge Cognition said it would bring its suite of touch-screen and voice-based digital assessments to the table, known for their precision and sensitivity in gauging cognition and other indicators of brain health.

"CNS disorders are characterised by a host of heterogeneous symptoms which impact daily life, but that are often inadequately addressed by existing treatments," said Cambridge Cognition's chief scientist Francesca Cormack.

"Our partnership with ActiGraph represents an exciting combination of expertise in objective digital measures of actigraphy, speech and cognition that will help accelerate the development of treatments for patients and improve efficiency in clinical trials."

At 1156 GMT, shares in Cambridge Cognition Holdings were down 0.62% at 51.18p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Billionaire Issa nearing deal to sell Asda stake to TDR Capital - report
(Sharecast News) - US private equity firm TDR Capital is reportedly closing in on a deal to buy petrol station billionaire Zuber Issa's stake in supermarket chain Asda.
Billionaire Issa nearing deal to sell Asda stake to TDR Capital
(Sharecast News) - Private equity firm TDR Capital is reportedly closing in on a deal to buy petrol station billionaire Zuber Issa's stake in supermarket chain Asda.
DS Smith tumbles as Mondi abandons pursuit
(Sharecast News) - DS Smith tanked on Friday after Mondi said it would not be making an offer for the rival packaging group, clearing the path for a takeover by International Paper.
Eqtec agrees amendment to Verde subscription
(Sharecast News) - Waste-to-energy technology developer Eqtec updated the market on the Verde Corporation subscription on Friday, confirming that an amendment to the subscription letter had been agreed upon with Verde.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.